Demant AS (WBO:DEMA) Other Current Liabilities: €540 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WBO:DEMA Demant AS WBO:DEMA
93 GF Score
Price €37.22
GF Value €41.99
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Demant AS Other Current Liabilities?

Demant AS WBO:DEMA -2.46% 93 Other Current Liabilities is €540 Mil as of Dec. 2025. GuruFocus rates WBO:DEMA with a GF Score™ of 93/100 and a GF Value™ of €41.99 (Modestly Undervalued). The stock has 8 warning signs investors should review.

Demant AS's other current liabilities for the quarter that ended in Dec. 2025 was €540 Mil.

Demant AS's quarterly other current liabilities declined from Dec. 2024 (€502 Mil) to Jun. 2025 (€469 Mil) but then increased from Jun. 2025 (€469 Mil) to Dec. 2025 (€540 Mil).

Demant AS's annual other current liabilities increased from Dec. 2023 (€436 Mil) to Dec. 2024 (€502 Mil) and increased from Dec. 2024 (€502 Mil) to Dec. 2025 (€540 Mil).

Demant AS Other Current Liabilities Related Terms

Demant AS Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Demant AS's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Demant AS Other Current Liabilities Chart

Demant AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 398.73 427.58 435.50 502.03 540.38

Demant AS Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 435.50 477.52 502.03 468.62 540.38
WBO:DEMA
93GF Score
Demant AS WBO:DEMA
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Demant AS Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of €540 Mil mean?
Demant AS (WBO:DEMA) has a Other Current Liabilities of €540 Mil as of Dec. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Demant AS.
Is Demant AS's Other Current Liabilities too high?
Demant AS's current Other Current Liabilities is €540 Mil. Overall, Demant AS has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Demant AS's Other Current Liabilities compare to ABT and SYK?
Demant AS's Other Current Liabilities of €540 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Demant AS. Demant AS's current Other Current Liabilities is €540 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Demant AS stock overvalued right now?
Based on GuruFocus' analysis, Demant AS (WBO:DEMA) is currently considered Modestly Undervalued. The stock's GF Value™ is €41.99, compared to a current price of €37.22 — trading 11.4% below its estimated fair value. The current Other Current Liabilities is €540 Mil. Demant AS's overall GF Score™ is 93/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Demant AS (WBO:DEMA), the current Other Current Liabilities is €540 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Demant AS (WBO:DEMA) Overvalued in 2026?

Based on GuruFocus' analysis, Demant AS stock appears to be undervalued. The current stock price of €37.22 is trading 11.4% below its estimated GF Value™ of €41.99. GuruFocus considers Demant AS to be Modestly Undervalued.

Key valuation signals for WBO:DEMA:

  • Other Current Liabilities: €540 Mil
  • GF Value™: €41.99 vs. price of €37.22 (11.4% below fair value)
  • GF Score™: 93/100 with 8 warning signs

No single metric tells the full story. See the WBO:DEMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Demant AS Business Description

Address Kongebakken 9, Smorum, DNK, 2765
Demant is a Denmark-based manufacturer and distributor of hearing solutions, such as hearing aid devices and diagnostic equipment. More than 80% of the company's sales come from North America and Europe.
93GF Score

Get the complete analysis for WBO:DEMA

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€37.22
Price
€41.99
GF Value